Brief: Dare Bioscience Inc Says On December 16, 2022 Co Received Notice Of Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Dec 16 (Reuters) - Dare Bioscience Inc DARE.O :
* DARE BIOSCIENCE INC - ON DECEMBER 16, 2022 CO RECEIVED
NOTICE
OF FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD FROM
NASDAQ
Further company coverage: DARE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dare Bioscience
See all newsBrief: Dare Bioscience - Files For Resale Of Up To 8,934,345 Shares Of Common Stock - SEC Filing
Brief: Daré Bioscience CEO Sabrina Martucci Johnson Named To Forbes 2026 “50 Over 50 Innovation” List
NASDAQ RESUMED AT 12:50 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:45 PM
Dare Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary